Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Pharmacogenomics Testing for Improving Pediatric ADHD Psychopharmacological Treatment: A Randomized Controlled Trial

NCT03730870 is registered in ClinicalTrials.gov with Clinical and Translational Genome Research Institute, Inc. as lead sponsor.

NCT NCT03730870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03730870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Pharmacogenomics Testing for Improving Pediatric ADHD Psychopharmacological Treatment: A Randomized Controlled Trial
Lead sponsor
Clinical and Translational Genome Research Institute, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2019
Completion date
February 28, 2020
Enrollment
21 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorders with hyperactivity